GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...

Owing to deregulated prices, Pakistan's pharmaceutical sector witnessed a remarkable surge in profitability, posting a 210% ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...

23andMe is a company on the ropes having filed for bankruptcy in the US. The one-time leader of the DNA analysis market – valued at $6 billion in 2021 – is now worth less than $50 million, a 99 ...

A locomotive-themed float, created by the Teesdale Railway History Group, will feature in the Barnard Castle Meet parade on Bank Holiday Monday, ...

Some of Liverpool's best loved cafes proudly boast glowing food hygiene reports, with their dedication to excellence rewarded ...

A GROUP of archers are in urgent need of a new outdoor venue for their club. Teesdale Archery Club can trace its roots back ...

Discover how Zydus Wellness is reinventing Complan, the iconic health drink, by expanding its target audience, leveraging ...

Biopharma deal activity climbed in early 2025, reaching $37.38 billion in the first two months, up from $35.66 billion a year ...

Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Glaxo due for a pullback? Before we ...